Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Other Non-Current Liabilities (2019 - 2024)

Updated

Pharming (PHAR) recorded Other Non-Current Liabilities of -$2.56 million in Q4 2025, compared with -$3.4 million a year earlier.

Analysis

Pharming (PHAR) Other Non-Current Liabilities (2019 - 2024) Analysis & Trends

Starting with Q4 2019, Pharming's Other Non-Current Liabilities history includes 9 quarters.

  • Across earlier years, Other Non-Current Liabilities came in at -$3.4 million in FY2024, -$3.24 million in FY2023 and -$25 million in FY2021.
  • The Q4 2025 figure is the highest quarterly Other Non-Current Liabilities since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -7.04 Mn
Dec 31, 2023 -3.24 Mn
Jun 30, 2021 71,000.00
Mar 31, 2021 25,103.00
Dec 31, 2020 25.04 Mn
Dec 31, 2019 19.98 Mn
API Access

Pharming Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PHAR&period=max&api_key=YOUR_API_KEY